 Therapeutic Implications of the Use of ODX in ER Positive, Node Positive Patients with Early Breast Cancer Norman Wolmark, MD Chairman and Principal Investigator of the National Surgical Adjuvant Breast and Bowel Project (NSABP), Professor and Chairman of Human Oncology, Drexel University School of Medicine Philadelphia, Pennsylvania אינך רואה את ההרצאה?, לחץ כאן |
| |
